Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici, A.; Emet, Samim; Cakmak, R.; YURUYEN, G.; Alibeyoglu, Alpay; AKARSU, M.; ARMAN, Yusuf; Kose, M.; OZGUN, Ersin; OZCAN, M.; ALTUN, O.; Onur, I.; Tukek, Tufan

doi:10.26355/eurrev_201806_15180

Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atıf İçin Kopyala

Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ...Daha Fazla

European review for medical and pharmacological sciences, cilt.22, sa.11, ss.3534-3543, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 11
Basım Tarihi: 2018
Doi Numarası: 10.26355/eurrev_201806_15180
Dergi Adı: European review for medical and pharmacological sciences
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.3534-3543
İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.